Skip to main content

Israeli company reveals nasal spray of psychedelic mushrooms

Madrigal Mental Care says the spray treats post-traumatic stress disorder, anxiety and other mental challenges. Some experts believe magic mushrooms have health benefits, though they come with risks.
Magic mushrooms sit in a fridge on July 18, 2005, in London, England.

Israel’s Madrigal Mental Care announced today a nasal spray featuring psychedelic mushrooms. 

The Beersheba-based biopharmaceutical company’s spray emits nanoparticles that encapsulate psilocybin, which is found in psychedelic mushrooms ("shrooms"). The spray also contains the pain drug ketamine, the recreational drug MDMA (molly or ecstasy) and other substances. The spray is designed to treat post-traumatic stress disorder (PTSD), anxiety, depression and other issues, Madrigal said in a press release. 

Access the Middle East news and analysis you can trust

Join our community of Middle East readers to experience all of Al-Monitor, including 24/7 news, analyses, memos, reports and newsletters.


Only $100 per year.